Document 0116 DOCN M9550116 TI A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. DT 9505 AU Parada CA; Yoon JB; Roeder RG; Laboratory of Biochemistry and Molecular Biology, Rockefeller; University, New York, New York 10021. SO J Biol Chem. 1995 Feb 3;270(5):2274-83. Unique Identifier : AIDSLINE MED/95138199 AB The cellular factor, LBP-1, can repress HIV-1 transcription by preventing the binding of TFIID to the promoter. Here we have analyzed the effect of recombinant LBP-1 on HIV-1 transcription in vitro by using a pulse-chase assay. LBP-1 had no effect on initiation from a preformed preinitiation complex and elongation to position +13 (pulse). However, addition of LBP-1 after RNA polymerase was stalled at +13 strongly inhibited further elongation (chase) by reducing RNA polymerase processivity. Severe mutations of the high affinity LBP-1 binding sites between 4 and +21 did not relieve the LBP-1-dependent block. However, LBP-1 could bind independently to upstream low affinity sites (-80 to -4), suggesting that these sites mediate the effect of LBP-1 on elongation. These results demonstrate a novel function of LBP-1, restricting HIV-1 transcription at the level of elongation. In addition, Tat was found to suppress the antiprocessivity effect of LBP-1 on HIV-1 transcription in nuclear extracts. These findings strongly suggest that LBP-1 may provide a natural mechanism for restricting the elongation of HIV-1 transcripts and that this may be a target for the action of Tat in enhancing transcription. DE Base Sequence DNA-Binding Proteins/*PHYSIOLOGY Gene Expression Regulation, Viral Gene Products, tat/METABOLISM Hela Cells Human HIV-1/*GENETICS In Vitro Molecular Sequence Data Mutagenesis, Site-Directed Promoter Regions (Genetics) Recombinant Proteins Repressor Proteins/*PHYSIOLOGY RNA Polymerases/*METABOLISM RNA, Viral/*BIOSYNTHESIS Structure-Activity Relationship Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Transcription, Genetic TATA Box JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).